Flamingo Therapeutics
Gaston Geenslaan 3 BLDG 4
3001 Leuven
BE
Flamingo Therapeutics
Foundation date
04/07/2019
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
The core business of Flamingo Therapeutics is the development of novel and innovative drugs for specific cancer types.Upcoming events
All events-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group -
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté
Latest news
More news-
reMYND announces positive Phase 2a clinical trial results for treatment of mild-to-moderate Alzheimer’s disease
Friday November 1st 2024
Read more
-
Can we protect nerve cells from dying?
Friday November 1st 2024
Read more
-
Resistance in Candida auris, how to tackle a deadly fungus
Wednesday October 30th 2024
Read more
Jobs
More jobsMore info?
Contact us
Ellen Telleir
Communication Coordinator